잠시만 기다려 주세요. 로딩중입니다.

Inborn Errors of Mitochondrial Fatty Acid Oxidation: Overview from a Clinical Perspective

Journal of Lipid and Atherosclerosis 2021년 10권 1호 p.1 ~ 7
소속 상세정보

Abstract


Mitochondrial fatty acid β-oxidation (mFAO), which is the major pathway for the degradation of fatty acids and is critical for maintaining energy homeostasis in the human body, consists of carnitine transport, the carnitine shuttle, and fatty acid β-oxidation. Inherited metabolic defects of mFAO result in more than 15 distinct mFAO disorders (mFAODs) with varying clinical manifestations. The common elements of the clinical presentation of mFAODs are hypoketotic hypoglycemia, (cardio)myopathy, arrhythmia, and rhabdomyolysis, indicating the importance of FAO during fasting or stressful situations. The management of all mFAODs includes avoidance of fasting, aggressive treatment during illness, and supplementation of carnitine or appropriate nutritional support, if necessary. Through the introduction of newborn screening using tandem mass spectrometry, early identification of mFAODs became feasible, leading to an early initiation of treatment with improved outcomes. However, many unmet needs remain with regard to the long-term management of patients with mFAODs.

키워드

Mitochondrial fatty acid β-oxidation (mFAO); Metabolic defects of mFAO

원문 및 링크아웃 정보

등재저널 정보